Chronic Myelogenous Leukemia (CML) is a myeloproliferative disorder characterized by the Philadelphia chromosome [1, 2], which originates from a reciprocal translocation involving the BCR gene on chromosome 22 and c-ABL on chromosome 9. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.